4//SEC Filing
Chung Jane 4
Accession 0001415889-25-006712
CIK 0001382101other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 6:42 PM ET
Size
12.7 KB
Accession
0001415889-25-006712
Insider Transaction Report
Form 4
Chung Jane
PRESIDENT AND COO
Transactions
- Exercise/Conversion
Common Stock
2025-03-01+25,000→ 102,217 total - Exercise/Conversion
Common Stock
2025-03-01+6,875→ 77,217 total - Tax Payment
Common Stock
2025-03-01$1.59/sh−9,450$15,026→ 92,767 total - Exercise/Conversion
Restricted Stock Unit (RSU)
2025-03-01−6,875→ 13,750 totalExp: 2027-03-01→ Common Stock (6,875 underlying) - Exercise/Conversion
Restricted Stock Unit (RSU)
2025-03-01−25,000→ 75,000 totalExp: 2028-03-01→ Common Stock (25,000 underlying)
Footnotes (4)
- [F1]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person.
- [F2]Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
- [F3]The RSUs vest as to 1/4th of the total shares annually beginning on March 1, 2024, subject to continued service through each vesting date.
- [F4]The RSUs vest as to 1/4th of the total award annually beginning on March 1, 2025, subject to continued service through each vesting date.
Documents
Issuer
SUTRO BIOPHARMA, INC.
CIK 0001382101
Entity typeother
Related Parties
1- filerCIK 0001872398
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 6:42 PM ET
- Size
- 12.7 KB